Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b, Multinational, Randomized, Double-blind Study to Investigate the Efficacy and Safety of Redasemtide (S-005151) Compared With Placebo in Adult Participants With Acute Ischemic Stroke

NCT05953480 is registered in ClinicalTrials.gov with Shionogi as lead sponsor.

NCT NCT05953480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05953480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b, Multinational, Randomized, Double-blind Study to Investigate the Efficacy and Safety of Redasemtide (S-005151) Compared With Placebo in Adult Participants With Acute Ischemic Stroke
Lead sponsor
Shionogi
Phase
Phase 2
Overall status
Completed
Start date
July 14, 2023
Completion date
June 15, 2026
Enrollment
680 (actual)
Sites
150

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke